Evidence map›Paper›PMID 42039510›Full record

ArticlebioRxiv : the preprint server for biology2026

Single-cell hit calling in high-content imaging screens with Buscar.

Erik Serrano, Wei-Shan Li, Gregory Way

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erik SerranoDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO.ORCID 0000-0003-4188-9080
Wei-Shan LiDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO.
Gregory WayDepartment of Biomedical Informatics, University of Colorado Anschutz, Aurora, CO.ORCID 0000-0002-0503-9348

Funding

Computational Bioscience Program Training GrantT15LM009451 · NLM · UNIVERSITY OF COLORADO DENVER · PI Katherina Kechris-Mays, Arjun Krishnan · 2007 to 2026
$11.7M
NLM NIH HHS T15 LM009451
6 · The paper itself

Abstract

High-content screening (HCS) enables the systematic quantification of single-cell morphology features across thousands of perturbations, capturing rich phenotypic heterogeneity. Image-based profiling is a critical bioinformatics processing step in this pipeline, as researchers use it to predict mechanisms of action, assess toxicity, perform hit calling, and more. However, current image-based profiling workflows rely on aggregate statistics, such as calculating mean or median feature values per well, implicitly assuming cell homogeneity. This limitation obscures subpopulation effects, reducing sensitivity to subtle or heterogeneous effects of perturbations. Here we present Buscar, a method that leverages the full heterogeneity of single-cell image-based profiles to call hits. Buscar requires two reference, single-cell populations that define distinct morphology states: a reference state (e.g., disease cells) and a target state (e.g., healthy cells). Buscar then compares these two groups to define on- and off-morphology signatures, which it then uses to score every perturbation in a given screen. The scores quantify perturbation efficacy and off-target effects, or specificity, in an interpretable manner, clarifying which morphologies are appropriately altered and which may arise from off-target activity. We apply Buscar to three datasets. First, as a proof of concept, we applied Buscar to a Cell Painting dataset of cardiac fibroblasts from patients with heart failure. Buscar quantifies both morphology rescue and off-target morphology activity in these cells treated with a TGFβ receptor inhibitor. Second, we show that Buscar recovers biologically coherent gene-phenotype associations across 16 manually-labeled phenotypes in the MitoCheck dataset. Lastly, applied to CPJUMP1, we show that Buscar is robust to technical replicates collected across plates in both small-molecule and CRISPR-Cas9 perturbations. Together, these results establish Buscar as a reproducible and interpretable hit calling method that overcomes aggregation bias, enabling the simultaneous quantification of compound efficacy and specificity to enhance hit calling in HCS. We release Buscar as an open-source python package.

Identifiers

PMID42039510
PMCPMC13104857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.